Lobbying Income
$5.0M
Filings
607
Unique Clients
15
Active Period
2005–2020
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Internet Radio Fairness Act of 2012
2012 · fourth_quarter · Client: PANDORA MEDIA, INC.
Royalty ratesetting for Internet radio, H.R. 6480; S. 3609.
Client expense: — · Firm income: —
Matched citations: H.R. 6480
Internet Radio Fairness Act of 2012
2012 · third_quarter · Client: PANDORA MEDIA, INC.
Royalty ratesetting for Internet radio, H.R. 6480; S. 3609.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 6480
Repealing the Job-Killing Health Care Law Act
2011 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2
Life Sciences Jobs and Investment Act of 2011
2011 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.2632
Preserving Access to Orphan Drugs Act of 2011
2011 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.2672
340B Program Improvement Act
2011 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.2674
Repealing the Job-Killing Health Care Law Act
2011 · third_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2
Life Sciences Jobs and Investment Act of 2011
2011 · third_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.2632
Preserving Access to Orphan Drugs Act of 2011
2011 · third_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.2672
340B Program Improvement Act
2011 · third_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation PDUFA reauthorization H.R.2632, S.1410 -- Life Sciences Jobs and Investment Act Orphan drugs H.R.2672, S.1423 -- Preserving Access to Orphan Drugs Act of 2011 H.R. 2 -- healthcare reform bill repeal Medicare rebates and reimbursement rates 340B drug discount program H.R.2674 -- 340B Program Improvement Act
Client expense: — · Firm income: $50,000
Matched citations: H.R.2674
Repealing the Job-Killing Health Care Law Act
2011 · second_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2
Repealing the Job-Killing Health Care Law Act
2011 · first_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 319 -- drug reimportation H.R. 2 -- healthcare reform bill repeal PDUFA reauthorization; Life sciences research tax credit legislation Orphan drug issues
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2
Combating Online Infringement and Counterfeits Act
2010 · fourth_quarter · Client: HOME RECORDING RIGHTS COALITION (HRRC)
S. 3804, Combating Online Infringement and Counterfeits Act.
Client expense: — · Firm income: $5,000
Matched citations: S. 3804
Combating Online Infringement and Counterfeits Act
2010 · fourth_quarter · Client: HOME RECORDING RIGHTS COALITION (HRRC)
S. 3804, Combating Online Infringement and Counterfeits Act.
Client expense: — · Firm income: $5,000
Matched citations: S. 3804
Safe Drug Disposal Act of 2009
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1191
Patent Reform Act of 2009
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1260
Pharmaceutical Market Access and Drug Safety Act of 2009
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1298
Secure and Responsible Drug Disposal Act of 2009
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1359
Protecting Consumer Access to Generic Drugs Act of 2009
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Client expense: — · Firm income: $60,000
Matched citations: H.R. 1706
Physician Payment and Therapy Relief Act of 2010
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Client expense: — · Firm income: $60,000
Matched citations: H.R. 5712
Life Sciences Jobs and Investment Act of 2010
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Client expense: — · Firm income: $60,000
Matched citations: H.R. 6165
Secure and Responsible Drug Disposal Act of 2009
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Client expense: — · Firm income: $60,000
Matched citations: S. 1292
Safe Drug Disposal Act of 2009
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Client expense: — · Firm income: $60,000
Matched citations: S. 1336
Preserve Access to Affordable Generics Act
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 369, H.R. 1706 -- patent settlements H.R. 1260, S. 515 -- patent reform
Client expense: — · Firm income: $60,000
Matched citations: S. 369
Life Sciences Jobs and Investment Act of 2010
2010 · fourth_quarter · Client: AMERICA'S SPECIALTY MEDICINE COMPANIES (COMPRISED OF PARTICIPANTS ON LINE 13)
S. 525, H.R. 1298 - drug reimportation H.R. 1191, H.R. 1359, S. 1292, S. 1336 - disposal of drugs; PDUFA reauthorization H.R. 5712 -- health care technical corrections H.R. 6165, S. 4018 - Life sciences research tax credit legislation
Client expense: — · Firm income: $60,000
Matched citations: S. 4018
Source: Senate LDA